Manipal Health Share Price: Shares Debut with Over 10% Gains on Indian Exchanges

Manipal Health share price made a strong debut on the Indian stock exchanges on 5 August 2026, listing at Rs 655 on the BSE, an 11.02 percent premium over its issue price of Rs 590, and at Rs 652 on the NSE, up 10.51 percent. The listing came as a pleasant surprise after several brokerages had flagged the possibility of a muted or flat debut in the days leading up to the listing.

Click Here – Get Free Investment Predictions

The Temasek-backed hospital chain raised Rs 9,275.22 crore through its public issue, comprising a fresh issue worth Rs 8,000 crore and an offer for sale of 2.16 crore shares worth Rs 1,275.22 crore by existing shareholders. The issue was subscribed 4.92 times overall, with strong institutional demand offsetting relatively muted retail interest.

Manipal Health Share Price: Listing Day Numbers at a Glance

Here is a snapshot of the Manipal Health share price and the numbers behind Wednesday's listing.

• Manipal Health share price on BSE: Rs 655, up 11.02 percent over the issue price of Rs 590.
• Manipal Health share price on NSE: Rs 652, up 10.51 percent over the issue price.
• Market capitalisation implied by the Manipal Health share price at listing: nearly Rs 85,763 crore, about 9 billion dollars.
• Issue size: Rs 9,275.22 crore, India's second-largest public issue so far this year.
• Overall subscription: 4.92 times, with the qualified institutional buyer portion subscribed 8.25 times and the retail portion subscribed 93 percent.
• Price band: Rs 560 to Rs 590 per share, with a lot size of 25 shares.

Why Manipal Health's Debut Beat Expectations

Ahead of the listing, several brokerages had pointed to the rich valuation implied by the Manipal Health share price at issue and the under-subscription in the retail category as reasons to expect a flat-to-discount debut, and unofficial grey market trackers had also signalled a muted outcome in the final days before listing. Grey market premium figures are unofficial, not always reliable, and can swing sharply right up to listing day, so it is worth checking a live grey market tracker separately for the latest reading rather than relying on any single estimate. In the end, strong demand from qualified institutional investors, who subscribed 8.25 times their portion, alongside a healthy anchor book of Rs 4,167 crore from investors including the Abu Dhabi Investment Authority and Allianz Global Investors Fund, appears to have outweighed the more cautious retail response.

About Manipal Health Enterprises

The company behind today's Manipal Health share price debut operates India's largest multispecialty hospital network by bed capacity, running 49 hospitals with over 13,000 beds across 14 states and union territories. The company served 7.63 million patients during FY26 and works with more than 11,000 doctors across its network. Manipal Health plans to add roughly 2,400 beds over the next three to four years, an expansion of more than 18 percent from its current capacity, and has earmarked Rs 5,378 crore from the fresh issue proceeds to repay or prepay borrowings at its subsidiary, Manipal Hospitals Private Limited. This scale and expansion pipeline are central to how analysts are framing the Manipal Health share price relative to smaller listed hospital chains.

Manipal Health Share Price vs Listed Hospital Peers

At its listing price, Manipal Health share price valuation works out to about 84.65 times its FY26 earnings, a premium to established peers such as Apollo Hospitals, with a market capitalisation of around Rs 1,30,000 crore, Max Healthcare, around Rs 1,04,000 crore, and Fortis Healthcare, around Rs 70,422 crore, all of which trade in a range of roughly 66 to 75 times earnings. The premium reflects Manipal Health's scale as India's largest hospital operator by bed count, though it also leaves less room for disappointment if growth or margins fall short of expectations.

Compare Hospital Stocks on the Univest Screener

Should You Buy Manipal Health Shares After Listing?

Some brokerages that flagged a cautious view on the Manipal Health share price ahead of listing have suggested that investors who received an allotment consider booking profits on any meaningful listing gains, while those looking to enter fresh may want to wait one to two quarters for clearer visibility on earnings growth and margin trends before deciding. The Manipal Health share price already reflects a rich valuation that leaves less cushion than some peers, so position sizing and time horizon matter more than usual here. This is not investment advice, and any decision should factor in your own risk appetite and financial goals.

Download the Univest iOS App or Univest Android App to track Manipal Health's live share price and hospital sector research.

Conclusion

Manipal Health share price wrapped up its first day of trading well ahead of the muted expectations that had built up in the run-up to listing, capping a subscription cycle where institutional investors showed far more conviction than retail bidders. With a large bed network, marquee anchor backers and an expansion plan already in motion, the Manipal Health share price pop of over 10 percent on debut sets a high bar, but its rich valuation relative to Apollo Hospitals, Max Healthcare and Fortis Healthcare means the coming quarters of execution will matter just as much as the listing day gains.

FAQs

What was the Manipal Health share price on listing day, 5 August 2026?

Ans. Manipal Health share price listed at Rs 655 on the BSE, an 11.02 percent premium to the issue price of Rs 590, and at Rs 652 on the NSE, up 10.51 percent.

What was the Manipal Health IPO issue price?

Ans. The Manipal Health share price at issue was fixed at Rs 590 per share, at the upper end of the Rs 560 to Rs 590 price band.

How many times was the Manipal Health IPO subscribed?

Ans. The issue was subscribed 4.92 times overall ahead of the Manipal Health share price debut, with the qualified institutional buyer portion subscribed 8.25 times and the retail portion subscribed 93 percent.

What is Manipal Health's market capitalisation after listing?

Ans. Manipal Health share price at listing valued the company at nearly Rs 85,763 crore, making it one of India's largest listed hospital operators by market value.

How does Manipal Health's valuation compare with Apollo Hospitals and other listed peers?

Ans. Manipal Health listed at about 84.65 times FY26 earnings, higher than Apollo Hospitals, Max Healthcare and Fortis Healthcare, which trade between roughly 66 and 75 times earnings.

Should I buy Manipal Health shares after the stock market debut?

Ans. This is not investment advice. Some brokerages have suggested allotted investors consider booking profits on listing gains, while fresh investors may want more clarity on earnings before entering; consult a SEBI-registered financial advisor before deciding.

Is this Manipal Health share price update investment advice?

Ans. No. This article is for informational and educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decision.